The incident rate of asymptomatic bacteriuria among LIMU students

Abstract

Asymptomatic bacteriuria is widespread; however, it is typically harmless. Asymptomatic bacteriuria screening and therapy are only advised for pregnant women or patients ahead forward certain invasive urogenital procedures. Asymptomatic bacteriuria in healthy women is associated with increased bouts of symptomatic infection, although antibiotic therapy of asymptomatic bacteriuria does not reduce the likelihood of these episodes. Clinical trials in patients with spinal cord injuries, diabetic women, patients with indwelling urethral catheters, and senior nursing home residents have repeatedly demonstrated no benefit from treating asymptomatic bacteriuria. Antimicrobial therapy can have bad repercussions, such as unpleasant medication effects including re-infection with organisms with developing resistance. The successful management of asymptomatic bacteriuria demands the immediate application of screening tools to support the identification of the chosen patients for whom medication is advantageous, as well as the avoiding of antimicrobial medication when no benefit has been demonstrated.